Want to see HK:2225 full AI Analyst Report?
Top Page
Jinhai International Group Holdings Limited
(2225)
Select Model
Select Model
Rating:54Neutral
Price Target:
HK$6.50
▲(424.19% Upside)
Action:Reiterated
Date:09/10/26
The score is held down primarily by weak financial performance (sharp margin compression, large losses, and negative operating/free cash flow over 2023–2025) and a loss-driven negative P/E. This is partially offset by strong technical momentum, with the stock trading well above key moving averages and a positive MACD.
Positive Factors
Recent Revenue Growth
Revenue growth in 2025 indicates the company continued expanding its top line despite broader profitability pressure. If maintained, this can support greater operating scale, improve the revenue base available to absorb fixed costs, and provide a platform for future margin recovery.
Negative Factors
Severe Margin Compression
The sharp, multi-year decline in gross margin signals substantial deterioration in the economics of the business. Lower gross profitability leaves less revenue available to cover operating costs, making earnings recovery harder and suggesting that pricing pressure or cost control issues may persist over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Recent Revenue Growth
Revenue growth in 2025 indicates the company continued expanding its top line despite broader profitability pressure. If maintained, this can support greater operating scale, improve the revenue base available to absorb fixed costs, and provide a platform for future margin recovery.
Read all positive factors
Jinhai International Group Holdings Limited (2225) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$30.36B
Dividend YieldN/A
Average Volume (3M)6.77M
Price to Earnings (P/E)―
Beta (1Y)0.36
Revenue Growth75.36%
EPS Growth49.21%
CountryHK
Employees485
SectorIndustrials
Sector Strength72
IndustryStaffing & Employment Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding5,299,000,000
10 Day Avg. Volume8,149,618
30 Day Avg. Volume6,769,991
Financial Highlights & Ratios
PEG Ratio10.95
Price to Book (P/B)21.00
Price to Sales (P/S)23.28
P/FCF Ratio-174.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Jinhai International Group Holdings Limited Business Overview & Revenue Model
Company Description
Jinhai Medical Technology Ltd. specializes in offering workforce solutions and a range of complementary support services. Catering primarily to building and construction contractors, their comprehensive service portfolio encompasses dormitory mana...
Jinhai International Group Holdings Limited Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
56
Neutral
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.07M | 46.28M | 50.24M | 45.64M | 22.28M | 21.90M |
| Gross Profit | 11.79M | 7.19M | 11.48M | 12.03M | 10.12M | 7.73M |
| EBITDA | -6.72M | -14.39M | -16.82M | 1.11M | 5.25M | 5.44M |
| Net Income | -11.23M | -17.08M | -17.96M | -3.14M | 468.00K | -246.21K |
Balance Sheet | ||||||
| Total Assets | 100.24M | 88.83M | 58.87M | 62.22M | 40.27M | 33.77M |
| Cash, Cash Equivalents and Short-Term Investments | 29.25M | 36.78M | 14.93M | 26.76M | 23.95M | 25.91M |
| Total Debt | 14.20M | 14.91M | 14.52M | 10.08M | 4.45M | 1.87M |
| Total Liabilities | 44.58M | 36.87M | 26.09M | 24.73M | 15.68M | 9.75M |
| Stockholders Equity | 51.91M | 51.28M | 31.81M | 37.47M | 24.37M | 24.28M |
Cash Flow | ||||||
| Free Cash Flow | 2.54M | -6.18M | -4.26M | -3.15M | 3.06M | 2.73M |
| Operating Cash Flow | 2.61M | -6.08M | -3.25M | -1.91M | 4.24M | 3.34M |
| Investing Cash Flow | 956.46K | 3.47M | -9.22M | -6.51M | -1.15M | -2.64M |
| Financing Cash Flow | 26.76M | 26.68M | 2.93M | 13.62M | -3.72M | -4.81M |
Jinhai International Group Holdings Limited Technical Analysis
Positive
1.24
Price Trends
4.35
Positive
4.09
Positive
2.91
Positive
Market Momentum
0.26
Negative
68.72
Neutral
73.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2225, the sentiment is Positive. The current price of 1.24 is below the 20-day moving average (MA) of 5.08, below the 50-day MA of 4.35, and below the 200-day MA of 2.91, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 68.72 is Neutral, neither overbought nor oversold. The STOCH value of 73.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2225.
Jinhai International Group Holdings Limited Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$1.03B | 5.40 | 15.17% | 35.98% | 6.09% | 21.21% | |
65 Neutral | HK$1.24B | 8.56 | 3.86% | 8.26% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | HK$30.36B | -496.85 | -21.76% | ― | 75.36% | 49.21% | |
54 Neutral | HK$553.37M | 4.17 | 8.42% | 5.41% | 9.13% | ― | |
44 Neutral | HK$108.20M | -3.36 | -43.31% | 29.46% | ― | ― | |
42 Neutral | HK$45.00M | -20.14 | -1.28% | ― | -14.98% | -120.83% |
* Industrials Sector Average
HK:2225
Jinhai International Group Holdings Limited
6.48
5.55
596.24%
HK:2180
ManpowerGroup Greater China Limited
4.92
-0.65
-11.67%
HK:6100
Tongdao Liepin Group
2.42
-1.07
-30.70%
HK:6919
Renrui Human Resources Technology Holdings Limited
3.51
-1.13
-24.35%
HK:8031
ETS Group Limited
0.28
0.16
133.33%
HK:8462
Omnibridge Holdings Ltd.
0.08
>-0.01
-8.54%
Jinhai International Group Holdings Limited Corporate Events
Jinhai Medical Narrows Interim Loss as Revenue More Than Doubles
Aug 27, 2026
Jinhai Medical Technology Limited reported a sharp rise in revenue to S$34.0 million for the six months ended 30 June 2026, more than doubling from S$14.5 million a year earlier, driven by improved business performance. Despite higher cost of sale...
Jinhai Medical Technology Sets Board Meeting to Approve Interim Results and Consider Dividend
Aug 4, 2026
Jinhai Medical Technology Limited has scheduled a board meeting for 27 August 2026 to review and approve the interim financial results for the six months ended 30 June 2026. The board will also consider the declaration of an interim dividend, indi...
Jinhai Medical Appoints Veteran CMO to Drive Minimally Invasive Growth
Aug 3, 2026
Jinhai Medical Technology Limited has appointed industry veteran Ma Chengdong as its chief marketing officer, effective 3 August 2026 for an initial one-year term, tasking him with leading marketing strategy, market access, academic promotion, sal...
Jinhai Medical Wins Strong Shareholder Backing at 2026 AGM
Jun 15, 2026
Jinhai Medical Technology Limited reported that all resolutions proposed at its annual general meeting held on 15 June 2026 were duly passed by shareholders via poll. The meeting covered the adoption of the 2025 audited financial statements, re-el...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.